Department of Internal Medicine, Seoul Veterans Hospital , Seoul , Korea and.
Ren Fail. 2014 Feb;36(1):23-7. doi: 10.3109/0886022X.2013.830360. Epub 2013 Sep 2.
The majority of hemodialysis (HD) patients are overhydrated and have high interdialytic weight gain (IDWG) which induces increased blood pressure (BP). The positive sodium balance resulting from a high sodium diet, a high dialysate sodium concentration (DNa), or a combination of both is major causes of this disease. We evaluated the effects of lowering DNa on IDWG, BP, and volume status in anuric HD patients with dietary sodium restriction.
Thirty-two patients were enrolled in this study and the period was divided by phase 1 and 2 according to DNa which decreased from 140 to 135 mEq/L at a rate of 1 mEq/L per month; phase 1, 140 mEq/L; phase 2, 135 mEq/L. We compared the IDWG, BP, volume status measured by multifrequency bioimpedance spectroscopy, and adverse events such as intradialytic hypotension, cramps, and headache of both phases.
The IDWG was significantly reduced by 0.39 ± 0.38 kg (p = 0.000). Pre-dialysis BP showed significant reduction (systolic pressure 146 ± 18 vs. 138 ± 22 mmHg; p = 0.012, diastolic pressure 80 ± 10 vs. 75 ± 11 mmHg; p = 0.008). Pre-dialysis extracellular water (ECW) was reduced significantly by 0.13 ± 2.22 L (p = 0.02). There was no significant increase in adverse events (all p > 0.05).
This study showed that gradually lowering DNa could bring a significant reduction in pre-dialysis IDWG, BP, and ECW without increased adverse events. Large and crossover designed study will be needed to demonstrate the clear causal relationship.
大多数血液透析(HD)患者存在水负荷过多和高透析间期体重增加(IDWG)的问题,这会导致血压升高。高钠饮食、高透析液钠浓度(DNa)或两者共同导致的正钠平衡是导致这种疾病的主要原因。我们评估了在接受饮食钠限制的无尿 HD 患者中降低 DNa 对 IDWG、血压和容量状态的影响。
本研究纳入了 32 名患者,并根据 DNa 分为第 1 阶段和第 2 阶段,DNa 每月降低 1 mEq/L,从 140 降至 135 mEq/L;第 1 阶段,DNa 为 140 mEq/L;第 2 阶段,DNa 为 135 mEq/L。我们比较了两个阶段的 IDWG、血压、多频生物电阻抗谱测量的容量状态以及透析中低血压、痉挛和头痛等不良事件。
IDWG 显著减少了 0.39±0.38kg(p=0.000)。透析前血压显示显著降低(收缩压 146±18 对 138±22mmHg;p=0.012,舒张压 80±10 对 75±11mmHg;p=0.008)。透析前细胞外液(ECW)显著减少了 0.13±2.22L(p=0.02)。不良事件无显著增加(均 p>0.05)。
本研究表明,逐渐降低 DNa 可显著减少透析前 IDWG、血压和 ECW,且不会增加不良事件。需要进行大型、交叉设计的研究来证明明确的因果关系。